Konblobet

Konblobet

bisoprolol

Manufacturer:

Konimex
Concise Prescribing Info
Contents
Bisoprolol fumarate
Indications/Uses
HTN, angina pectoris & stable chronic heart failure w/ declining left ventricular function. Adjunctive to ACE inhibitors, diuretics & cardiac glycosides if necessary.
Dosage/Direction for Use
HTN or angina pectoris 1 tab once daily, may be increased to 2 tab daily. Max: 4 tab daily. Stable chronic heart failure Initially 1.25 mg daily in 1st wk then titrate dose to 2.5, 3.75-5 mg daily every wk. Continue to titrate dose to 7.5-10 mg daily every mth. Maintenance dose: Based on patient's tolerability.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Acute heart failure or during episodes of heart failure decompensation requiring IV inotropic therapy, cardiogenic shock, 2nd or 3rd degree AV block, sick sinus syndrome, SA block, symptomatic bradycardia & hypotension, severe bronchial asthma, late stages of peripheral arterial occlusive disease or Raynaud's syndrome, untreated phaeochromocytoma, metabolic acidosis.
Special Precautions
Patients w/ HTN or angina pectoris w/ heart failure, ischemic heart disease. Avoid abrupt discontinuation.
Adverse Reactions
Bradycardia, dizziness, headache, GI problems eg, nausea, vomiting, diarrhea, constipation. Feeling of coldness or numbness in the extremities; asthenia, fatigue.
MIMS Class
Beta-Blockers
ATC Classification
C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Konblobet FC tab 5 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in